Identification of leukaemic cells in bone marrow and blood samples by a new cytofluorometric assay
1996

New Test for Detecting Leukaemia Cells

Sample size: 14 publication Evidence: moderate

Author Information

Author(s): M Hengstschlager, M Pfeilstdcker, Edgar Wawra

Primary Institution: Institute of Molecular Biology, University of Vienna

Hypothesis

Can a new cytofluorometric assay effectively identify leukaemic cells in blood and bone marrow samples?

Conclusion

The new cytofluorometric assay successfully identifies leukaemic cells among normal cells, demonstrating its potential for leukaemia diagnosis.

Supporting Evidence

  • The assay can identify malignant cells mixed with a 10,000-fold excess of normal cells.
  • The method is applicable to fresh samples and can provide results within 3 hours.
  • Thymidine kinase activity is a general indicator of malignant growth.

Takeaway

Scientists created a new test that helps doctors find cancer cells in blood samples, even when there are a lot of normal cells around.

Methodology

The study involved using a cytofluorometric assay to measure thymidine kinase activity in blood and bone marrow samples from leukaemia patients.

Limitations

The assay may not be specific for all types of leukaemia and requires further morphological and genetic studies for accurate diagnosis.

Participant Demographics

Patients with acute lymphocytic leukaemia (ALL) and acute myelogeneous leukaemia (AML) were included.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication